New Evidence Supporting the Use of Mineralocorticoid Receptor Blockers in Drug-Resistant Hypertension

Treatment resistant hypertension (TRH), defined as a blood pressure above goal despite treatment with optimally tolerated doses of 3 antihypertensive agents of different classes, ideally including a diuretic, remains a significant problem and its management an area of uncertainty for physicians. One...

Descripción completa

Detalles Bibliográficos
Autores principales: Narayan, Hafid, Webb, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Hypertension and the Kidney (RM Carey, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829620/
https://www.ncbi.nlm.nih.gov/pubmed/27072827
http://dx.doi.org/10.1007/s11906-016-0643-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829620/
https://www.ncbi.nlm.nih.gov/pubmed/27072827
http://dx.doi.org/10.1007/s11906-016-0643-8

Ejemplares similares